Level Four Advisory Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.42M | Sell |
58,789
-7,774
| -12% | -$203K | 0.04% | 374 |
|
|
2026
Q1 | $1.87M | Sell |
66,563
-9,465
| -12% | -$252K | 0.06% | 299 |
|
|
2025
Q4 | $1.89M | Buy |
76,028
+671
| +0.9% | +$16.9K | 0.06% | 289 |
|
|
2025
Q3 | $1.92M | Buy |
75,357
+4,356
| +6% | +$108K | 0.07% | 276 |
|
|
2025
Q2 | $1.72M | Sell |
71,001
-92,053
| -56% | -$2.15M | 0.06% | 273 |
|
|
2025
Q1 | $4.13M | Buy |
163,054
+8,190
| +5% | +$214K | 0.17% | 168 |
|
|
2024
Q4 | $4.11M | Sell |
154,864
-9,265
| -6% | -$251K | 0.17% | 160 |
|
|
2024
Q3 | $4.64M | Sell |
164,129
-56,218
| -26% | -$1.64M | 0.2% | 152 |
|
|
2024
Q2 | $6.17M | Buy |
220,347
+126,313
| +134% | +$3.48M | 0.28% | 92 |
|
|
2024
Q1 | $2.71M | Buy |
94,034
+276
| +0.3% | +$7.66K | 0.15% | 165 |
|
|
2023
Q4 | $2.7M | Sell |
93,758
-36,197
| -28% | -$1.09M | 0.15% | 162 |
|
|
2023
Q3 | $4.31M | Sell |
129,955
-23,616
| -15% | -$835K | 0.28% | 93 |
|
|
2023
Q2 | $5.63M | Buy |
153,571
+2,221
| +1% | +$86.4K | 0.34% | 60 |
|
|
2023
Q1 | $6.18M | Sell |
151,350
-2,958
| -2% | -$128K | 0.41% | 47 |
|
|
2022
Q4 | $7.91M | Buy |
154,308
+30,369
| +25% | +$1.46M | 0.59% | 34 |
|
|
2022
Q3 | $5.42M | Buy |
123,939
+2,603
| +2% | +$126K | 0.53% | 42 |
|
|
2022
Q2 | $6.36M | Buy |
121,336
+6,570
| +6% | +$335K | 0.6% | 36 |
|
|
2022
Q1 | $5.94M | Sell |
114,766
-5,729
| -5% | -$297K | 0.47% | 47 |
|
|
2021
Q4 | $7.12M | Buy |
120,495
+24,926
| +26% | +$1.23M | 0.54% | 34 |
|
|
2021
Q3 | $4.11M | Sell |
95,569
-31,114
| -25% | -$1.38M | 0.43% | 61 |
|
|
2021
Q2 | $4.96M | Buy |
126,683
+8,696
| +7% | +$338K | 0.34% | 61 |
|
|
2021
Q1 | $4.28M | Sell |
117,987
-3,144
| -3% | -$112K | 0.33% | 71 |
|
|
2020
Q4 | $4.46M | Sell |
121,131
-10,530
| -8% | -$386K | 0.36% | 68 |
|
|
2020
Q3 | $4.58M | Buy |
131,661
+18,241
| +16% | +$640K | 0.35% | 65 |
|
|
2020
Q2 | $3.51M | Buy |
113,420
+6,114
| +6% | +$208K | 0.27% | 90 |
|
|
2020
Q1 | $3.32M | Sell |
107,306
-7,061
| -6% | -$241K | 0.4% | 54 |
|
|
2019
Q4 | $12.4M | Buy |
114,367
+10,528
| +10% | +$375K | 0.49% | 58 |
|
|
2019
Q3 | $3.54M | Buy |
103,839
+9,673
| +10% | +$352K | 0.37% | 60 |
|
|
2019
Q2 | $3.87M | Sell |
94,166
-1,629
| -2% | -$64.7K | 0.39% | 58 |
|
|
2019
Q1 | $3.86M | Sell |
95,795
-1,121
| -1% | -$44.9K | 0.43% | 55 |
|
|
2018
Q4 | $4.01M | Sell |
96,916
-622
| -0.6% | -$25.8K | 0.5% | 46 |
|
|
2018
Q3 | $4.08M | Sell |
97,538
-35,456
| -27% | -$1.36M | 0.44% | 53 |
|
|
2018
Q2 | $4.58M | Sell |
132,994
-2,549
| -2% | -$87.1K | 0.33% | 72 |
|
|
2018
Q1 | $4.56M | Buy |
135,543
+3,734
| +3% | +$128K | 0.35% | 66 |
|
|
2017
Q4 | $4.53M | Buy |
131,809
+4,200
| +3% | +$143K | 0.35% | 65 |
|
|
2017
Q3 | $4.32M | Buy |
127,609
+24,775
| +24% | +$796K | 0.38% | 57 |
|
|
2017
Q2 | $3.34M | Sell |
102,834
-35,653
| -26% | -$1.12M | 0.51% | 46 |
|
|
2017
Q1 | $4.49M | Sell |
138,487
-927
| -0.7% | -$29.2K | 0.46% | 50 |
|
|
2016
Q4 | $4.3M | Buy |
+139,414
| New | +$4.26M | 0.55% | 31 |
|
Other funds holding PFE
Level Four Advisory Services's PFE Position: Q2 2026 in Review
Level Four Advisory Services reduced its Pfizer (PFE) stake by 12% in Q2 2026, selling an estimated $203K and leaving 58,789 shares worth $1.42M. The position accounts for 0.04% of the portfolio, ranked #374.
Level Four Advisory Services first reported a position in PFE in Q4 2016 and has held it in 39 quarters since. The position peaked at $12.4M in Q4 2019. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Level Four Advisory Services held 58,789 shares of Pfizer worth $1.42M as of Q2 2026.
- Level Four Advisory Services sold 7,774 Pfizer shares in Q2 2026, an estimated $203K.
- Pfizer made up 0.04% of Level Four Advisory Services's portfolio in Q2 2026, its #374 holding.
- Level Four Advisory Services first reported a position in Pfizer in Q4 2016 and has held it in 39 quarters since.
- Level Four Advisory Services's Pfizer position peaked at $12.4M in Q4 2019.
- 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Level Four Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.